Table 2.
The change in clinical characteristics after 8 weeks of intervention in both groups
| Characteristic | Vitamin C (n=31) (mean ± SD)
|
Control (n=33) (mean ± SD)
|
P-value | ||
|---|---|---|---|---|---|
| Before | After | Before | After | ||
| hs-CRP (mg/L) | 14.86±9.20 | 7.74±4.53* | 14.50±14.26 | 11.81±7.33 | 0.01** |
| IL-6 (pg/mL) | 2.20±0.75 | 1.40±0.53* | 1.95±0.75 | 2.01±0.87 | 0.001** |
| FBG (mg/dL) | 188.13±81.24 | 126.16±34.06* | 187.15±64.89 | 161.91±37.97* | <0.001** |
| TC (mg/dL) | 207.71±36.20 | 196.48±33.89 | 211.03±39.04 | 213.38±38.77 | 0.071 |
| TG (mg/dL) | 223.81±87.88 | 155.10±48.12* | 202.91±107.00 | 183.45±95.82* | 0.138 |
Notes:
*
Change was significant at the 0.05 level (two-tailed) (calculated by paired-samples t-test).
**
Difference was significant at the 0.05 level (two-tailed) (calculated by independent-samples t-test).
Abbreviations: FBG, fasting blood glucose; hs-CRP, high-sensitivity C-reactive protein; IL-6, interleukin 6; SD, standard deviation; TC, total cholesterol; TG, triglyceride.